Comments

Moderna: Efficacy Is 94.5% — 1 Comment

  1. That’s excellent news, especially the part about severe cases. I realize it’s easier to count the number of cases with minor symptoms, but what we need from the vaccine is protection against infectiousness, protection against severe disease, or preferably both. Protection against getting a low-grade fever and a cough isn’t, by itself, all that useful. It looks like Moderna’s mRNA-1273 might provide excellent protection against both infectiousness and severe disease.

Leave a Reply

Your email address will not be published. Required fields are marked *

HTML tags allowed in your comment: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>